This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 4/6).

In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca.

AI, bioinformatics, and computational biology are reshaping how cancer drugs are discovered and developed. Tommy explains how data-driven insights—from target identification to clinical trial analysis—are accelerating timelines, improving precision, and unlocking personalized medicine. What once took a decade may soon take less, saving lives and transforming the future of healthcare.

Tune in for valuable insights on:

Overcoming challenges in data science

Embracing AI in healthcare

Leveraging technology to revolutionize healthcare

You can connect with our host, René Bastón, on LinkedIn: https://www.linkedin.com/in/renebaston/

And our guest, Tommy Tang, on LinkedIn: https://www.linkedin.com/in/🎯-ming-tommy-tang-40650014/

For more information on any of the topics discussed, visit the Hill Research Podcast at https://www.hillresearch.ai/podcast.